JP2021515791A - シリコーンアクリルハイブリッドポリマーを含む経皮治療システム - Google Patents

シリコーンアクリルハイブリッドポリマーを含む経皮治療システム Download PDF

Info

Publication number
JP2021515791A
JP2021515791A JP2020548759A JP2020548759A JP2021515791A JP 2021515791 A JP2021515791 A JP 2021515791A JP 2020548759 A JP2020548759 A JP 2020548759A JP 2020548759 A JP2020548759 A JP 2020548759A JP 2021515791 A JP2021515791 A JP 2021515791A
Authority
JP
Japan
Prior art keywords
activator
treatment system
silicone
transdermal treatment
transdermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2020548759A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021515791A5 (cg-RX-API-DMAC7.html
Inventor
マルコ・エムゲンブロイフ
ガーブリエル・ヴァウアー
ミカエル・リン
ロルフ・ベーム
クリストフ・シュミッツ
レギーネ・カウフマン
ハンス−ヴェルナー・ヴォルフ
ニコ・ロイム
アンナ・シュリューター
Original Assignee
エルテーエス ローマン テラピー−ジステーメ アーゲー
エルテーエス ローマン テラピー−ジステーメ アーゲー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エルテーエス ローマン テラピー−ジステーメ アーゲー, エルテーエス ローマン テラピー−ジステーメ アーゲー filed Critical エルテーエス ローマン テラピー−ジステーメ アーゲー
Publication of JP2021515791A publication Critical patent/JP2021515791A/ja
Publication of JP2021515791A5 publication Critical patent/JP2021515791A5/ja
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2020548759A 2018-03-13 2019-03-11 シリコーンアクリルハイブリッドポリマーを含む経皮治療システム Abandoned JP2021515791A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18161436.3 2018-03-13
EP18161436 2018-03-13
PCT/EP2019/056025 WO2019175106A1 (en) 2018-03-13 2019-03-11 Transdermal therapeutic system comprising a silicone acrylic hybrid polymer

Publications (2)

Publication Number Publication Date
JP2021515791A true JP2021515791A (ja) 2021-06-24
JP2021515791A5 JP2021515791A5 (cg-RX-API-DMAC7.html) 2022-03-16

Family

ID=61628188

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020548759A Abandoned JP2021515791A (ja) 2018-03-13 2019-03-11 シリコーンアクリルハイブリッドポリマーを含む経皮治療システム

Country Status (7)

Country Link
US (1) US20210008000A1 (cg-RX-API-DMAC7.html)
EP (1) EP3764997A1 (cg-RX-API-DMAC7.html)
JP (1) JP2021515791A (cg-RX-API-DMAC7.html)
CN (1) CN111971033A (cg-RX-API-DMAC7.html)
BR (1) BR112020018290A2 (cg-RX-API-DMAC7.html)
CA (1) CA3092752A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019175106A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3069698T3 (en) * 2023-09-28 2026-06-09 Lts Lohmann Therapie Systeme Ag Transdermal therapeutic system comprising cytisine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US6974588B1 (en) * 1999-12-07 2005-12-13 Elan Pharma International Limited Transdermal patch for delivering volatile liquid drugs
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
KR101432698B1 (ko) 2006-06-06 2014-08-22 다우 코닝 코포레이션 실리콘 아크릴레이트 하이브리드 조성물
RU2544702C2 (ru) 2009-04-24 2015-03-20 Хенкель Корпорейшн Клеи на основе силикон-акрилового гибридного полимера
JP2013139554A (ja) * 2011-11-29 2013-07-18 Dow Corning Corp シリコーンアクリレートハイブリッド組成物及び該組成物の製造方法
EA201491164A1 (ru) 2011-12-12 2014-10-30 ЭлТиЭс ЛОМАНН ТЕРАПИ-ЗЮСТЕМ АГ Трансдермальная система доставки
AU2013205080B2 (en) * 2012-12-12 2016-07-07 Lts Lohmann Therapie-Systeme Ag Transdermal Delivery System
KR102048682B1 (ko) 2015-02-09 2019-11-27 다우 실리콘즈 코포레이션 다중상 실리콘 아크릴 하이브리드 점탄성 조성물 및 이의 제조 방법
US20170112781A1 (en) * 2015-10-27 2017-04-27 Noven Pharmaceuticals, Inc. Transdermal drug delivery systems with polyisobutylene face adhesive
WO2018015424A1 (en) * 2016-07-22 2018-01-25 Lts Lohmann Therapie-Systeme Ag Control of adhesive domains

Also Published As

Publication number Publication date
EP3764997A1 (en) 2021-01-20
US20210008000A1 (en) 2021-01-14
WO2019175106A1 (en) 2019-09-19
BR112020018290A2 (pt) 2020-12-29
CN111971033A (zh) 2020-11-20
CA3092752A1 (en) 2019-09-19

Similar Documents

Publication Publication Date Title
JP7660162B2 (ja) シリコーンポリマーを含むグアンファシンの経皮投与のための経皮治療システム
JP7549641B2 (ja) シリコーン含有ポリマーを含む活性剤含有層及びシリコーンゲル接着剤を含む皮膚接触層を含む経皮治療システム
JP2021517576A (ja) ニコチン及びシリコーンアクリルハイブリッドポリマーを含有する経皮治療システム
JP2021515789A (ja) シリコーンアクリルハイブリッドポリマーを含む経皮治療システム
JP2020525546A (ja) スコポラミン及びシリコーンアクリルハイブリッドポリマーを含有する経皮治療システム
JP2021517572A (ja) シリコーンアクリルハイブリッドポリマーを含む経皮治療システム
CN112040936B (zh) 用于透皮施用索利那新的透皮治疗系统
JP7641279B2 (ja) フィンゴリモドの経皮投与のための経皮治療システム
JP2021517569A (ja) シリコーンアクリルハイブリッドポリマーを含む、ブプレノルフィンの経皮投与のための経皮治療システム
US20210008000A1 (en) Transdermal therapeutic system comprising a silicone acrylic hybrid polymer
HK40043162A (en) Transdermal therapeutic system for the transdermal administration of solifenacin

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220308

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220308

A762 Written abandonment of application

Free format text: JAPANESE INTERMEDIATE CODE: A762

Effective date: 20221028